Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

The document concludes that skin and nail changes can indicate various underlying health conditions.

New treatments for male hypogonadism are effective and should be personalized.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Korean Red Ginseng may protect against hair loss caused by chemotherapy.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.